tiprankstipranks

David Nicholson Insider Profile

4 Followers
David Nicholson, Director at Actinium Pharmaceuticals, holds 10.00K shares in Actinium Pharmaceuticals (Ticker: ATNM), holds ― shares in Adverum Biotechnologies (Ticker: ADVM). Most recently, David Nicholson Bought ― shares of Actinium Pharmaceuticals on Apr 18, 2016 for an estimated value of 10.00K.
tipranks
David Nicholson

David Nicholson
Actinium Pharmaceuticals (ATNM)
Director

Not Ranked
David Nicholson has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$99K
100.00%
0.00%
A breakdown of David Nicholson's holdings

Insider Roles

Actinium Pharmaceuticals
(ATNM)
Director
Adverum Biotechnologies
(ADVM)
Director
Roles that David Nicholson holds in companies

Most Profitable Insider Trade

Stock:
Actinium Pharmaceuticals
(ATNM)
Rating:Informative Buy
Date:Apr 18, 2016 - Apr 18, 2017
Return:-22.60%
The most profitable trade made by David Nicholson

David Nicholson's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Actinium Pharmaceuticals
Apr 18, 2016
Director
Informative Buy
10.00K
$98.50K
Adverum Biotechnologies
Director
List of latest transactions for each holding click on a transaction to see David Nicholson's performance on stock

David Nicholson insider profile FAQ

What is the percentage of profitable transactions made by David Nicholson?
The percentage of profitable transactions made by David Nicholson is ―.
    What is the average return per transaction made by David Nicholson?
    The average return per transaction made by David Nicholson is ―.
      What stocks does David Nicholson hold?
      David Nicholson holds: ATNM, ADVM stocks.
        What was David Nicholson’s latest transaction?
        David Nicholson latest transaction was an Informative Buy of $10.00K.
          What was David Nicholson's most profitable transaction?
          David Nicholson’s most profitable transaction was an Informative Buy of ATNM stock on April 18, 2016. The return on the trade was -22.60%.
            What is David Nicholson's role in Actinium Pharmaceuticals?
            David Nicholson's role in Actinium Pharmaceuticals is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.